ArticleCureus2025
A Tailored Enhanced Recovery After Surgery (ERAS) Approach for Acute Pain Management in Elective Cesarean Deliveries: A Randomized Controlled Trial.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Cesarean delivery is a significant milestone in a mother's life, often marked by joy. However, the postoperative period can be physically challenging, especially for those undergoing the procedure due to maternal or fetal indications. Objectives This study aimed to evaluate the effectiveness of a tailored enhanced recovery after surgery (ERAS) protocol in managing acute pain following elective cesarean deliveries. Traditional protocols often prolong maternal discomfort and delay recovery. Methods Eligible patients who provided written informed consent were randomized into two groups: the ERAS protocol (EP) group and the routine protocol (RP) group. Both groups underwent comprehensive preanesthetic evaluations, including history-taking, systemic examination, airway assessment, and standard blood investigations. Patients in the EP group were allowed to consume clear fluids up to two hours before surgery, whereas those in the RP group adhered to the conventional six-hour fasting protocol. Results Each group included 50 patients. Intraoperative shivering was significantly lower in the EP group (22.7%; five patients) compared to the RP group (77.3%; 17 patients) (p < 0.005). Hypotension occurred in 10 EP patients versus 32 in the RP group (p < 0.005). At 24 hours post-surgery, pain scores measured using the Visual Analogue Scale were significantly lower in the EP group both at rest (1.76 ± 0.82 vs. 2.96 ± 0.95) and during movement (2.46 ± 0.81 vs. 3.78 ± 0.89) (p < 0.005 for both). Opioid use was also markedly reduced in the EP group, with only two patients (4%) requiring opioids postoperatively, compared to 25 patients (50%) in the RP group (p < 0.005). Conclusions The tailored ERAS protocol significantly improved acute postoperative pain management in cesarean deliveries. Patients in the ERAS group experienced fewer intraoperative complications, reduced opioid consumption, faster mobilization, shorter hospital stays, and higher overall satisfaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.